Lithium in the over-65s--a dedicated monitoring service leads to a better quality of treatment supervision.
Fielding
S
S
Kerr
S
S
Godber
C
C
D000368:Aged; D018692:Antimanic Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000097:blood / Q000188:drug therapy*; D016903:Drug Monitoring; D004739:England; D005260:Female; D015577:Geriatric Assessment; D006299:Health Services for the Aged; D006801:Humans; D016651:Lithium Carbonate / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D008297:Male
D018692:Antimanic Agents; D016651:Lithium Carbonate